10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS.

Davies, Christina; Pan, Hongchao; Peto, Richard

Davies, Christina; Pan, Hongchao; Peto, Richard.

Afiliación

Davies C; ATLAS International Co-ordinating Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: Christina.Davies@ndph.ox.ac.uk.
Pan H; ATLAS International Co-ordinating Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Peto R; ATLAS International Co-ordinating Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Lancet ; 389(10082): 1884, 2017 05 13.

Article en En | MEDLINE | ID: mdl-28457628

Asunto(s)

Neoplasias de la Mama; Tamoxifeno; Antineoplásicos Hormonales; Quimioterapia Adyuvante; Humanos; Receptores de Estrógenos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama Límite: Humans Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google